rct
    1984

    Failure of lysine in frequently recurrent herpes simplex infection: treatment and prophylaxis

    DiGiovanna JJ, Blank H

    Published in Archives of Dermatology

    Key Findings

    Oral lysine hydrochloride 1200 mg/day did not reduce recurrence rate, duration or severity of herpes simplex episodes versus placebo.

    Conclusions

    Well-conducted negative trial at moderate dose.

    Limitations

    Small crossover sample, older methodology.

    Supplements Studied

    L-Lysine
    Amino Acid

    Lysine hydrochloride did not reduce the rate, duration or severity of recurrent herpes simplex episodes compared with placebo.

    Study Details

    Year:1984
    Sample Size:21
    Duration:52 weeks
    Quality Score:6/10

    Access Study

    View on DOIView on PubMedOriginal Source

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.